Considerable researches of antitumor drugs demonstrate that blocking the Nrf2 signalling pathway can reduce tumour recurrence rates and increase tumour sensitivity to radiotherapy and chemotherapy drugs (Cong et al. The gene discussed is NFE2L2; the disease is neoplasm.